Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Excision BioTherapeutics presented new data from its CRISPR-based therapies targeting hepatitis B virus (EBT-107) and herpes simplex virus keratitis (EBT-104) at the ASGCT 2025 Annual Meeting in New Orleans.
Excision BioTherapeutics' EBT-101, a CRISPR-based gene editing therapy, demonstrates safety and temporary HIV infection suppression in early trials.